Advertisement

Drugs

, Volume 58, Supplement 2, pp 361–363 | Cite as

Surveillance of Antimicrobial Resistance among Respiratory Tract Pathogens in the United States, 1997 to 1998

  • Clyde Thornsberry
  • Mary L. Hickey
  • James Kahn
  • Yolanda Mauriz
  • Daniel F. SahmEmail author
Poster Presentations Extended Abstract

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kronenberger CB, Hoffman RE, Lezotte DC, et al. Invasive penicillin-resistant pneumococcal infections: a prevalence and historical cohort study. Emerg Infect Dis 1996; 2: 121–4PubMedCrossRefGoogle Scholar
  2. 2.
    Doern GV, Brueggemann A, Holley Jr HP, et al. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40: 1208–13PubMedGoogle Scholar
  3. 3.
    Jorgensen JH, Doern GV, Maher LA, et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990; 34: 2075–80PubMedCrossRefGoogle Scholar
  4. 4.
    Spika JS, Facklam RR, Plikaytis BD, et al. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979–1987. The Pneumococcal Surveillance Working Group. J Infect Dis 1991; 163: 1273–8PubMedCrossRefGoogle Scholar
  5. 5.
    Thornsberry C, Ogilvie P, Kahn J, et al. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season. The Laboratory Investigator Group. Diagn Microbiol Infect Dis 1997; 29: 249–57PubMedCrossRefGoogle Scholar
  6. 6.
    Breiman RF, Butler JC, Tenover FC, et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831–5PubMedCrossRefGoogle Scholar
  7. 7.
    Butler JC, Hofmann J, Cetron MS, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention’s Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174: 986–93PubMedCrossRefGoogle Scholar
  8. 8.
    Pfaller MA, Jones RN, Doern GV, et al. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 1998; 42: 1762–70PubMedGoogle Scholar
  9. 9.
    Thornsberry C, Ogilvie PT, Holley Jr HP, et al. In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance. Clin Ther 1998; 20: 1179–90PubMedCrossRefGoogle Scholar
  10. 10.
    American Society for Microbiology. Manual of Clinical Microbiology. 6th ed. Murray PR, Baron EJ, Pfaller MA, et al., editors. Washington, DC: American Society for Microbiology Press, 1995Google Scholar
  11. 11.
    National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing. 8th informational supplement. Approved standard M100-S8. Villanova, Pennsylvania, 1998Google Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Clyde Thornsberry
    • 1
  • Mary L. Hickey
    • 2
  • James Kahn
    • 3
  • Yolanda Mauriz
    • 3
  • Daniel F. Sahm
    • 2
    Email author
  1. 1.MRL Pharmaceutical ServicesBrentwoodUSA
  2. 2.MRL Pharmaceutical ServicesHerndonUSA
  3. 3.Ortho-McNeil PharmaceuticalRaritanUSA

Personalised recommendations